FDA confirms efficacy of Pfizer COVID-19 vaccine, on cusp of EUA

Editor's Note

The Food and Drug Administration (FDA), on December 8, released documents that confirmed the safety and efficacy of Pfizer’s COVID-19 vaccine, the Associated Press reports. The vaccine was co-developed with BioNTech.

FDA regulators posted their analysis online, as the UK began administering doses of the vaccine to its oldest citizens. 

The FDA review also found evidence that the vaccine, which is given in two doses, 3 weeks apart began to protect people after the first dose.

On December 10, a panel of independent scientists will analyze the FDA’s review to determine if the agency should issue an emergency use authorization (EUA) to begin vaccinating the first recipients.